CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vandenbark, G. R.
Right arrow Articles by Kaufman, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vandenbark, G. R.
Right arrow Articles by Kaufman, R. E.

Cell Growth & Differentiation, Vol 7, Issue 10 1383-1392, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Complex regulation of human c-kit transcription by promoter repressors, activators, and specific myb elements

GR Vandenbark, Y Chen, E Friday, K Pavlik, B Anthony, C deCastro and RE Kaufman
Department of Medicine, Louisiana State University Medical Center, Shreveport 71130-3932, USA.

The c-kit proto-oncogene is expressed in several tissues during development. To understand the mechanisms controlling the expression of this gene, we characterized the human c-kit promoter. Expression is controlled transcriptionally. The 5'-flanking DNA was used to make promoter deletion-reporter constructs that were tested in cells that were either positive or negative for endogenous c-Kit. The results demonstrate that DNA, to at least position -4100, directs transcription well in both positive and negative cells. Addition of DNA from position -4100 to -5500 causes a reduction in expression to near-basal levels in c-Kit-negative cells but has little effect in c-Kit-positive cells. The DNA from -4100 to -5500 was tested for repressor function. It inhibits transcription from some heterologous promoters in c-Kit-negative cells. Likewise, this segment inhibits transcription from the homologous proximal promoter in a cell-specific manner, but the entire promoter is necessary for complete repression in c-Kit-negative cells. Two Myb binding motifs were also identified, and their role in regulating transcription was examined by mutation and functional testing. One, MYB1, acts as a partial repressor, whereas the other, MYB2, is a positive element that appears essential for expression. Binding proteins to both sites were characterized by several methods. MYB1 binds and responds functionally to c-Myb, but MYB2 does not. The results of these studies indicate that the regulation of c-kit transcription is complex, involving interactions among several activators and repressors.


This article has been cited by other articles:


Home page
G3Home page
V. A. David, M. Menotti-Raymond, A. C. Wallace, M. Roelke, J. Kehler, R. Leighty, E. Eizirik, S. S. Hannah, G. Nelson, A. A. Schaffer, et al.
Endogenous Retrovirus Insertion in the KIT Oncogene Determines White and White spotting in Domestic Cats
g3, January 25, 2017; 4(10): 1881 - 1891.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
S. Matsumoto, T. Kurimoto, M. M. Taketo, S. Fujii, and A. Kikuchi
The WNT/MYB pathway suppresses KIT expression to control the timing of salivary proacinar differentiation and duct formation
Development, July 1, 2016; 143(13): 2311 - 2324.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. Mithraprabhu and K. L Loveland
Control of KIT signalling in male germ cells: what can we learn from other systems?
Reproduction, November 1, 2009; 138(5): 743 - 757.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Zhao, G. Gomez, S.-H. Yu, J. J. Ryan, and L. B. Schwartz
TGF-{beta}1 Attenuates Mediator Release and De Novo Kit Expression by Human Skin Mast Cells through a Smad-Dependent Pathway
J. Immunol., November 15, 2008; 181(10): 7263 - 7272.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Nakata, S. Shetzline, C. Sakashita, A. Kalota, R. Rallapalli, S. I. Rudnick, Y. Zhang, S. G. Emerson, and A. M. Gewirtz
c-Myb Contributes to G2/M Cell Cycle Transition in Human Hematopoietic Cells by Direct Regulation of Cyclin B1 Expression
Mol. Cell. Biol., March 15, 2007; 27(6): 2048 - 2058.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. E. Shetzline, R. Rallapalli, K. J. Dowd, S. Zou, Y. Nakata, C. R. Swider, A. Kalota, J. K. Choi, and A. M. Gewirtz
Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias
Blood, September 15, 2004; 104(6): 1833 - 1840.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X.-M. You, I. N. Mungrue, W. Kalair, T. Afroze, B. Ravi, A. M. Sadi, R. Gros, and M. Husain
Conditional Expression of a Dominant-Negative c-Myb in Vascular Smooth Muscle Cells Inhibits Arterial Remodeling After Injury
Circ. Res., February 21, 2003; 92(3): 314 - 321.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Vitelli, G. Condorelli, V. Lulli, T. Hoang, L. Luchetti, C. M. Croce, and C. Peschle
A Pentamer Transcriptional Complex Including tal-1 and Retinoblastoma Protein Downmodulates c-kit Expression in Normal Erythroblasts
Mol. Cell. Biol., July 15, 2000; 20(14): 5330 - 5342.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Afroze and M. Husain
c-Myb-binding Sites Mediate G1/S-associated Repression of the Plasma Membrane Ca2+-ATPase-1 Promoter
J. Biol. Chem., March 24, 2000; 275(12): 9062 - 9069.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Schmidt, V. Nazarov, L. Stevens, R. Watson, and L. Wolff
Regulation of the Resident Chromosomal Copy of c-myc by c-Myb Is Involved in Myeloid Leukemogenesis
Mol. Cell. Biol., March 15, 2000; 20(6): 1970 - 1981.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. von Lindern, W. Zauner, G. Mellitzer, P. Steinlein, G. Fritsch, K. Huber, B. Lowenberg, and H. Beug
The Glucocorticoid Receptor Cooperates With the Erythropoietin Receptor and c-Kit to Enhance and Sustain Proliferation of Erythroid Progenitors In Vitro
Blood, July 15, 1999; 94(2): 550 - 559.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. H. Park, H. K. Plummer III, and G. W. Krystal
Selective Sp1 Binding Is Critical for Maximal Activity of the Human c-kit Promoter
Blood, December 1, 1998; 92(11): 4138 - 4149.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Gewirtz, D. L. Sokol, and M. Z. Ratajczak
Nucleic Acid Therapeutics: State of the Art and Future Prospects
Blood, August 1, 1998; 92(3): 712 - 736.
[Full Text] [PDF]


Home page
BloodHome page
M. Z. Ratajczak, D. Perrotti, P. Melotti, M. Powzaniuk, B. Calabretta, K. Onodera, D. A. Kregenow, B. Machalinski, and A. M. Gewirtz
Myb and Ets Proteins Are Candidate Regulators of c-kit Expression in Human Hematopoietic Cells
Blood, March 15, 1998; 91(6): 1934 - 1946.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. He, C. M. deCastro, G. R. Vandenbark, J. Busciglio, and D. Gabuzda
Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene
PNAS, April 15, 1997; 94(8): 3954 - 3959.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J. Coffman, C. Kirchhamer, M. Harrington, and E. Davidson
SpMyb functions as an intramodular repressor to regulate spatial expression of CyIIIa in sea urchin embryos
Development, January 12, 1997; 124(23): 4717 - 4727.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.